Effect of apomorphine on cognitive performance and sensorimotor gating in humans
โ Scribed by Arnt F. A. Schellekens; K. P. Grootens; C. Neef; Kris L. L. Movig; J. K. Buitelaar; B. Ellenbroek; R. J. Verkes
- Publisher
- Springer
- Year
- 2009
- Tongue
- English
- Weight
- 230 KB
- Volume
- 207
- Category
- Article
- ISSN
- 0033-3158
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Deanol (900 mg/day for 21 days) had no effect on learning a list of words when tested at weekly intervals. Tests of simple and complex reaction time and a test of continuous serial decoding of digits showed no enhancement with the drug. Several components of evoked potentials recorded from several s
## Abstract Apomorphine is a dopamine receptor agonist increasingly used in the treatment of Parkinson's disease (PD). In the present study, we examined the plasma and ventricular cerebrospinal fluid (CSF) pharmacokinetics of apomorphine as well as its effects on dopamine metabolism in six patients